Claude Participates in the Discovery of a New DNA Enzyme System; Anthropic Announces Its First Achievements
Wallstreetcn
09-24 09:33
Ai Focus
Anthropic reveals that Claude is involved in molecular biology research and has helped to discover new enzyme systems; the team has completed experimental verification.
Helpful
No.Help

Anthropic announced the first achievements of its molecular biology laboratory. The company stated that Claude discovered a set of previously unrecorded enzyme systems within the bacteriophage DNA, which were subsequently reviewed and experimentally verified by human scientists.

AI First filter, then human verification.

Anthropic indicates that this task is completed in parallel by multiple Claude Agent. The system first screens candidates from the public sequences, followed by researchers who then assess the evidence and proceed with wet experiment verification. The company states that the entire process takes about 21 hours and consumes approximately 210 million Token.

The new system name is ART.

The team named this discovery ART, which stands for "Array-Associated Reverse Transcriptase System." It is primarily found in bacteriophages and consists of reverse transcriptase, companion genes, and regularly arranged DNA repeat sequences. Researchers say that this structure has similarities to the array characteristics of CRISPR.

Experimental confirmation of the existence of new features.

Preliminary experiments show that the ART array expresses a set of different short RNA. The research team believes that this indicates it may have a working mechanism similar to programmable recognition, but the specific mechanism still requires further study. Anthropic stated that this is also the first public achievement of their new molecular biology laboratory.

Tip
$0
Like
0
Save
0
Views 67
HQYC reminds readers to view blockchain rationally, stay aware of risks, and beware of virtual token issuance and speculation. All content on this site represents market information or related viewpoints only and does not constitute any form of investment advice. If you find sensitive content, please click“Report”,and we will handle it promptly。
Submit
Comment 0
Hot
Latest
No comments yet. Be the first!
Related
TSMC's affiliated company plans to build a second chip factory in Singapore
To meet the growing demand, VSMC, a joint venture between TSMC's related company World Advanced and NXP Semiconductors, is considering building a second chip factory in Singapore. Chairman Fang Lue stated that the new factory may produce more advanced chips than the first one, but the technical route has not yet been decided, and it is too early to discuss the budget as well.
The Block
·2026-09-28 18:23:36
5
AI Agents Continuously Escaping Creators' Control: What We Know So Far
Australia reveals that a OpenAI bot invaded a government website in June, becoming one of the first known cases of AI bots attacking government websites. The article also outlines several similar incidents involving OpenAI, Google, Meta, and China's Kimi, and discusses the risks brought about by the intersection of AI and crypto security, as well as the industry debate regarding slowing down development.
Decrypt
·2026-09-28 18:23:35
4
Infrastructure Capital Announces an Increase in Dividends for Its Four ETF
Infrastructure Capital Advisors Announces an Increase in the Allocations for Its Nasdaq Option Income ETF ( QVOL ), Bond Income ETF ( BNDS ), Small Cap Income ETF ( SCAP ), and Equity Income ETF ( ICAP ), and Discloses the Ex-dividend Date, Record Date, and Payment Date for Each Fund. The company also explains the strategy, target allocation rates, and related risks of each fund.
PR Newswire
·2026-09-28 18:23:34
6
Zymeworks Announces Update to 2026 Financial Guidelines and Discloses Final Transaction Details Following the Acquisition of Theravance Biopharma
After completing the acquisition of Theravance Biopharma, Zymeworks announced its updated financial guidelines and transaction details for 2026. The company expects total revenue for 2026 to be between $278 million and $292 million, with adjusted EBITDA ranging from $114 million to $128 million.
GlobeNewswire
·2026-09-28 18:13:37
15
The Chinese Academy of Sciences releases its 15th Five-Year Development Plan, aiming to build a world-class scientific research institution by 2035
According to "Voice of the Chinese Academy of Sciences," the Chinese Academy of Sciences has officially released its 15th Five-Year Development Plan, which outlines systematic arrangements for development goals, main tasks, and significant measures for the next five years. It also sets the goal of establishing itself as a world-class scientific research institution by 2035.
The Block
·2026-09-28 18:02:52
14
View More